CSL Behring

Updated on Nov 16, 2023

Edit

Comment

Number of employees 14,000+ Parent organization CSL Limited		Founded 2000

Key people Paul Perreault, CEO and Managing Director of CSL Limited Website http://www.cslbehring.com/ CEO Paul Perreault (1 Jul 2013–) Headquarters Pennsylvania, United States Subsidiaries Csl Plasma Inc., Aventis Bio-Services Inc. Profiles LinkedIn Twitter YouTube

Csl behring shipping sensitive medication with fedex

CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products. Its line of therapies includes products for the treatment of bleeding disorders such as hemophilia and von Willebrand Disease; primary immune deficiencies (PIDD); hereditary angioedema; inherited respiratory disease; and neurological disorders in certain markets. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in the newborn.

CSL Behring operates the plasma collection network, CSL Plasma.

Csl behring

Company Statistics

Parent Company: CSL Limited, (ASX:CSL), Melbourne, Australia
Headquarters: King of Prussia, PA
Employees: 14,000+
Operations: In 30 countries
CEO and Managing Director: Paul Perreault
R&D: Marburg, Germany; Bern, Switzerland; King of Prussia, Pennsylvania, USA; Tokyo, Japan; Broadmeadows and Parkville, Victoria, Australia.

History

CSL Behring is a member of the CSL Group of companies. Parent company CSL Limited (ASX: CSL) is a specialty biopharmaceutical company headquartered in Parkville, Australia. As part of a global alignment, the CSL Behring brand was established in 2007. Previously known as ZLB Behring, the company's history dates back to 1904.

CSL Behring traces its heritage back to Emil von Behring, the inventor of serum therapy or serology.

Products

CSL Behring researches, develops, manufactures and markets a range of plasma-derived and recombinant products and related services, specializing in the treatment of rare and serious diseases. Its line of therapies includes products for the treatment of bleeding disorders such as hemophilia and von Willebrand Disease; primary immune deficiencies; hereditary angioedema; inherited respiratory disease; and neurological disorders in certain markets. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in the newborn.[1]

Immunology:

Beriglobin P, human hepatitis A immunoglobulin, liquid 16% solution for intramuscular injection

Berirab P, human rabies immunoglobulin, liquid 16% solution for intramuscular injection

Carimune NF, Sandoglobulin, Sanglopor human normal immunoglobulin, freeze-dried formulations for intravenous administration

Cytogam, human cytomegalovirus immunoglobulin. Liquid immunoglobulin containing a standardized amount of antibody to cytomegalovirus.

Hepatitis B Immunoglobulin P Behring, human hepatitis B immunoglobulin, liquid 16% solution for intramuscular injection

Hizentra,Human normal immunoglobulin. Liquid 20% immunoglobulin solution, ready-to-use for subcutaneous administration

Privigen, human polyvalent immunoglobulin, liquid 10% solution for intravenous injection

Rhophylac human anti-D immunoglobulin. Prefilled syringes of highly purified anti-Rhesus factor D IgG for intravenous administration and intramuscular injection.

Tetagam P, human tetanus immunoglobulin, liquid 16% solution for intramuscular injection

Varicellon P, human varicella immunoglobulin, liquid 16% solution for intramuscular injection

Coagulation/Bleeding Disorders:

Beriate, freeze-dried human coagulation factor VIII concentrate

Berinin P, freeze-dried human coagulation factor IX concentrate

Beriplex P/N, KCentra, a non-activated 4-Factor Prothrombin complex concentrate (4F-PCC) for urgent Warfarin reversal

Factor X P Behring, a freeze-dried human coagulation factor IX and factor X concentrate

Fibrogammin P and Corifact, freeze-dried human coagulation factor XIII concentrate

Helixate FS and Helixate NexGen, freeze-dried recombinant coagulation factor VIII

Humate-P and Haemate P, freeze-dried human coagulation factor VIII: C and von Willebrand factor concentrate

IDELVION, freeze-dried recombinant coagulation factor IX Albumin fusion protein

Monoclate P, a freeze-dried monoclonal antibody purified human coagulation factor VIII concentrate

Mononine, a freeze-dried human coagulation factor IX that has been purified using monoclonal antibodies

Octostim, a synthetic desmopressin acetate nasal spray

RiaSTAP human coagulation factor I, freeze-dried factor I concentrate

Stimate, a synthetic desmopressin acetate nasal spray

Pulmonary:

Zemaira, freeze-dried Human Alpha₁-proteinase inhibitor (A₁-PI)

Critical Care:

AlbuRx, Alburex, Human Albumin Behring, Albuminar, human albumin solution (5%, 20% or 25% human albumin solutions)

Berinert P, freeze-dried human C₁-esterase inhibitor (C1-INH) concentrate

Beriplex P/N, Kcentra, freeze-dried human prothrombin complex concentrate

Haemocomplettan P, RiaSTAP, freeze-dried human fibrinogen (factor I) concentrate

Kybernin P, freeze-dried human antithrombin III concentrate

Streptase, freeze-dried streptokinase

Wound Healing:

Beriplast P Combi-Set, fibrin sealant kit, freeze-dried fibrin sealant for topical application

Fibrogammin P, freeze-dried human coagulation factor XIII concentrate

TachoComb, fibrin sealant fleece-type, fleece-type collagen preparations coated with fibrin glue components

(Note: Product availability varies from country to country, depending on registration status.)

Offices

The company is headquartered in King of Prussia, Pennsylvania. It has 14,000+ employees in 30 countries. Major manufacturing centers are located in Bern, Switzerland, Marburg, Germany, Kankakee, Illinois, and Broadmeadows, Australia.

References

CSL Behring Wikipedia

(Text) CC BY-SA